135 related articles for article (PubMed ID: 3302313)
1. Clavulanate-potentiated amoxycillin: in vitro antibacterial activity and oral bioavailability in calves.
Soback S; Bor A; Kurtz B; Paz R; Ziv G
J Vet Pharmacol Ther; 1987 Jun; 10(2):105-13. PubMed ID: 3302313
[TBL] [Abstract][Full Text] [Related]
2. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
Bywater RJ; Palmer GH; Buswell JF; Stanton A
Vet Rec; 1985 Jan; 116(2):33-6. PubMed ID: 3871985
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
Livermore DM; Seetulsingh P
J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
Corbel MJ; Ibrahim ME; Gill KP
Vet Rec; 1984 Nov; 115(18):465. PubMed ID: 6568786
[No Abstract] [Full Text] [Related]
5. Beta-lactamase evaluation of the amoxycillin-clavulanate association.
Novelli A; Reali EF; Fallani S; Periti P
Drugs Exp Clin Res; 1989; 15(4):151-4. PubMed ID: 2505995
[TBL] [Abstract][Full Text] [Related]
6. Amoxycillin/clavulanic acid: the effect of probenecid.
Staniforth DH; Jackson D; Clarke HL; Horton R
J Antimicrob Chemother; 1983 Sep; 12(3):273-5. PubMed ID: 6630111
[TBL] [Abstract][Full Text] [Related]
7. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
8. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
Seetulsingh PS; Hall LM; Livermore DM
J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
[TBL] [Abstract][Full Text] [Related]
9. Parenteral augmentin: pharmacokinetics.
Staniforth DH; Jackson D; Horton R; Davies B
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):430-4. PubMed ID: 6490225
[TBL] [Abstract][Full Text] [Related]
10. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
Brown EM
J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
[TBL] [Abstract][Full Text] [Related]
11. Divergent disk susceptibility of coagulase-negative staphylococci to penicillinase-resistant penicillins and augmentin (amoxycillin/clavulanic acid).
Traub WH
Chemotherapy; 1985; 31(2):119-23. PubMed ID: 3872778
[TBL] [Abstract][Full Text] [Related]
12. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.
Maesen FP; Davies BI; Baur C
J Antimicrob Chemother; 1987 Mar; 19(3):373-83. PubMed ID: 3494724
[TBL] [Abstract][Full Text] [Related]
13. A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993.
Rolinson GN
J Chemother; 1994 Oct; 6(5):283-318. PubMed ID: 7861195
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology of mecillinam in calves.
Soback S; Bor A; Paz R; Ziv G
J Vet Pharmacol Ther; 1986 Dec; 9(4):385-93. PubMed ID: 3543397
[TBL] [Abstract][Full Text] [Related]
15. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
Stein GE; Gurwith MJ
Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of enteric pathogens to amoxicillin and clavulanate-potentiated amoxicillin.
Mégraud F; Gavinet A
Chemioterapia; 1987 Jun; 6(2 Suppl):75-6. PubMed ID: 3334666
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of a syrup formulation of amoxycillin-potassium clavulanate in children.
Schaad UB; Casey PA; Ravenscroft AT
J Antimicrob Chemother; 1986 Mar; 17(3):341-5. PubMed ID: 3700293
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of clavulanate-potentiated amoxycillin in experimental and clinical skin infections.
Bywater RJ; Hewett GR; Marshall AB; West B
Vet Rec; 1985 Feb; 116(7):177-9. PubMed ID: 3887742
[TBL] [Abstract][Full Text] [Related]
19. Activity of amoxycillin/clavulanate against beta-lactamase-producing Escherichia coli and Klebsiella spp.
Roy C; Segura C; Torrellas A; Reig R; Teruel D; Hermida M
J Antimicrob Chemother; 1989 Nov; 24 Suppl B():41-7. PubMed ID: 2691485
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of flumequine in calves.
Ziv G; Soback S; Bor A; Kurtz B
J Vet Pharmacol Ther; 1986 Jun; 9(2):171-82. PubMed ID: 3522937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
